Updating a Healthcare System-wide Clinical Pathway for Managing Chest Pain and Acute Coronary Syndromes.
Journal
Critical pathways in cardiology
ISSN: 1535-2811
Titre abrégé: Crit Pathw Cardiol
Pays: United States
ID NLM: 101165286
Informations de publication
Date de publication:
01 Dec 2023
01 Dec 2023
Historique:
medline:
28
11
2023
pubmed:
2
10
2023
entrez:
2
10
2023
Statut:
ppublish
Résumé
Clinical pathways are useful tools for conveying and reinforcing best practices to standardize care and optimize patient outcomes across myriad conditions. The NewYork-Presbyterian Healthcare System has utilized a clinical chest pain pathway for more than 20 years to facilitate the timely recognition and management of patients presenting with chest pain syndromes and acute coronary syndromes. This chest pain pathway is regularly updated by an expanding group of key stakeholders, which has extended from the Columbia University Irving Medical Center to encompass the entire regional healthcare system, which includes 8 hospitals. In this 2023 update of the NewYork-Presbyterian clinical chest pain pathway, we present the key changes to the healthcare system-wide clinical chest pain pathway.
Identifiants
pubmed: 37782621
doi: 10.1097/HPC.0000000000000334
pii: 00132577-990000000-00050
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
103-109Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Références
Tsao CW, Aday AW, Almarzooq ZA, et al. Heart disease and stroke statistics – 2022 update: a report from the American Heart Association. Circulation. 2022;145:e153–e639.
Zilinyi RS, Stant JA, Sayan OR, et al. Twenty years of an institutional chest pain pathway: what’s come and what’s yet to come. Crit Pathw Cardiol. 2023;22:41–44.
Brener M, Tung J, Stant J, et al. An updated healthcare system-wide clinical pathway for managing patients with chest pain and acute coronary syndromes. Crit Pathw Cardiol. 2019;18:167–175.
Collet JP, Thiele H, Barbato E, et al. 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment Elevation of the European Society of Cardiology (ESC). Eur Heart J. 2021;42:2298.
Gulati M, Levy PD, Mukherjee D, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines. Circulation. 2021;144:e368–e454.
Neumann JT, Sorensen NA, Schwemer T, et al. Diagnosis of myocardial infarction using a high-sensitivity Troponin I 1-Hour algorithm. JAMA Cardiol. 2016;1:397–404.
Twerenbold R, Neumann JT, Sorensen NA, et al. Prospective validation of the 0/1-hour algorithm for early diagnosis of myocardial infarction. J Am Coll Cardiol. 2018;72:620–632.
Twerenbold R, Badertscher P, Boeddinghaus J, et al. 0/1-Hour triage algorithm for myocardial infarction in patients with renal dysfunction. Circulation. 2018;137:436–451.
Boeddinghaus J, Nestelberger T, Twerenbold R, et al.; APACE, BACC, and TRAPID-AMI Investigators. Impact of age on the performance of the ESC 0/1-Hour algorithms for early diagnosis of myocardial infarction. Eur Heart J. 2018;39:3780–3794.
Smalley CM, Fertel BS, McShane AJ, et al. Outcomes in emergency department patients with intermediate elevations in high-sensitive cardiac Troponin T. Am J Emerg Med. 2023;65:212–213.
Biviano AG, Bergmann SR, Tenenbaum J, et al. Design of a comprehensive chest pain initiative in an academic urban hospital. Crit Pathw Cardiol. 2003;2:113–117.
Goyal N, Stant J, Esposito F, et al. Updating the chest pain algorithm incorporating new evidence. Crit Pathw Cardiol. 2008;7:211–222.
Galper BZ, Stant J, Reilly M, et al. Updating the chest pain algorithm incorporating new evidence on emerging antiplatelet agents. Crit Pathw Cardiol. 2011;10:9–16.
Rosner GF, Stone GW, Stant J, et al. Updating and institutional chest pain algorithm incorporating new evidence on emerging pharmacotherapy. Crit Pathw Cardiol. 2012;11:107–113.
Kelly CR, Kirtane AJ, Stant J, et al. An updated protocol for evaluating chest pain and managing acute coronary syndromes. Crit Pathw Cardiol. 2017;16:7–14.
Ranard LS, Ahmad Y, Masoumi A, et al. Clinical pathway for management of suspected or positive novel coronavirus-19 patients with ST-segment elevation myocardial infarction. Crit Pathw Cardiol. 2020;19:49–54.
Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction(2018). Circulation. 2018;138:e618–e651.
Ibanez B, James S, Agewall S, et al.; ESC Scientific Document Group. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-Segment Elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-Segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39:119–177.
Lemkes JS, Janssens GN, van der Hoeven NW, et al. Coronary angiography after cardiac arrest without ST-Segment Elevation. N Engl J Med. 2019;380:1397–1407.
Desch S, Freund A, Akin I, et al.; TOMAHAWK Investigators. Angiography after out-of-hospital cardiac arrest without ST-Segment elevation. N Engl J Med. 2021;385:2544–2553.
Ibanez B, Macay C, Sánchez-Brunete V, et al. Effect of early metoprolol on infarct size in ST-Segment-Elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARDCNIC) trial. Circulation. 2013;128:1495–1503.
Roolvink V, Ibáñez B, Ottervanger JP, et al.; EARLY-BAMI Investigators. EARLY-BAMI investigators. early intravenous beta-blockers in patients with ST-Segment Elevation myocardial infarction before primary percutaneous coronary intervention. J Am Coll Cardiol. 2016;67:2705–2715.
Bugiardini R, Cenko E, Ricci B, et al. Comparison of early versus delayed oral β blockers in acute coronary syndromes and effect on outcomes. Am J Cardiol. 2016;117:760–767.